D2 antagonists, methods of synthesis and methods of use
US9156840B2 · kind B2 · utility
0Cited by
4References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 19, 2014 |
| Grant date | Oct 13, 2015 |
| Priority date | — |
| Expiry date | Feb 19, 2034 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are D2 or D3 antagonist compounds and pharmaceutical compositions of formula Iand pharmaceutically acceptable salts thereof, or isomers thereof, wherein R1, R2 and R3 are as defined herein. The invention further comprises methods for making the compounds of the invention and methods for the treatment of conditions mediated by the dopamine D2 or D3 receptor from the compounds of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.